Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $165,993 - $193,630
1,723 Added 8.74%
21,445 $2.21 Million
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $2.31 Million - $2.45 Million
-21,558 Reduced 52.22%
19,722 $2.15 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $2.58 Million - $4.7 Million
41,280 New
41,280 $4.7 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $7.71 Million - $11.3 Million
97,141 Added 11.92%
911,752 $72.7 Million
Q1 2022

May 13, 2022

BUY
$86.42 - $109.81 $41.2 Million - $52.3 Million
476,600 Added 141.0%
814,611 $85.7 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $33.3 Million - $40.5 Million
338,011 New
338,011 $36.4 Million
Q3 2021

Nov 12, 2021

SELL
$91.91 - $110.37 $4.41 Million - $5.3 Million
-48,011 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $4.14 Million - $4.61 Million
48,011 New
48,011 $4.5 Million
Q3 2020

Nov 12, 2020

SELL
$55.23 - $79.93 $480,501 - $695,391
-8,700 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$30.2 - $56.98 $262,740 - $495,726
8,700 New
8,700 $484,000
Q3 2019

Nov 14, 2019

SELL
$23.0 - $27.97 $9.09 Million - $11 Million
-395,041 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $9.01 Million - $11.3 Million
395,041 New
395,041 $9.51 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.